Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers

被引:8
作者
Farr, Stephen J. [1 ]
Robinson, Cynthia Y. [1 ]
Rubino, Christopher M. [2 ,3 ]
机构
[1] Zogenix Inc, 5858 Horton St,Suite 455, Emeryville, CA 94608 USA
[2] Inst Clin Pharmacodynam, Latham, NY USA
[3] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
关键词
opioid; food interaction; alcohol interaction; bioavailability; norhydrocodone; hydromorphone;
D O I
10.2147/CPAA.S70831
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The purpose of this study was to evaluate the pharmacokinetics, bioavailability, and safety of oral extended-release hydrocodone (HC-ER) when administered with food or alcohol. Methods: Two single-center, open-label, randomized, crossover studies were conducted in healthy volunteers. In a two-period food-interaction study, 12 subjects received HC-ER 20 mg after an overnight fast and a high-fat meal. In a three-period alcohol-interaction study, 30 naltrexone-blocked subjects received HC-ER 50 mg with a 0%, 20%, or 40% alcohol/orange juice solution after an overnight fast. Pharmacokinetic parameters were derived from plasma concentrations of hydrocodone and its metabolites. Results: Exposure to hydrocodone after HC-ER 20 mg was similar in the fed and fasted states, as assessed by area under the plasma concentration versus time curve from time of dosing to time of last detectable concentration (AUC(0-t); 316.14 versus 311.94 ng . h/mL); relative bioavailability (F-rel) was 101.74%. Differences (fed versus fasted) in hydrocodone mean maximum plasma concentration (C-max; 28.86 versus 22.74 ng/mL) and median time to C-max (t(max); 6 versus 8 hours) were not clinically significant. Administration of 20% alcohol with HC-ER 50 mg did not increase systemic exposure relative to 0% alcohol (AUC(0-t) 878 versus 832 ng . h/mL; F-rel 105%) or result in clinically meaningful changes in C-max (51.8 versus 46.3 ng/mL) or t(max) (5.44 versus 6.16 hours). Administration with 40% alcohol increased AUC(0-t) (1,008 ng . h/mL versus 832 ng . h/mL; F-rel 120%) and C-max (109 versus 46.3 ng/mL), and shortened t(max) (2.43 versus 6.16 hours). Adverse events occurred in 10.0%, 24.1%, and 66.7% of subjects after 0%, 20%, and 40% alcohol, respectively. Conclusion: HC-ER can be administered without regard to meals. While there was no evidence of "dose-dumping" (an unintended, rapid release in a short time period of all or most of the hydrocodone from HC-ER), even with 40% alcohol, as with all opioids, alcohol should not be ingested while using HC-ER.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 28 条
[1]  
[Anonymous], 2013, VIC ES VIC HP HYDR B
[2]  
[Anonymous], 2014, OXYM HYDR EXT REL TA
[3]  
[Anonymous], 2013, EMB MORPH SULF NALTR
[4]  
[Anonymous], 2013, NUCYNT ER TAP EXT RE
[5]  
[Anonymous], 2013, EXALG HYDR HCI EXT R
[6]  
[Anonymous], 2013, ZOH ER HYDR BIT EXT
[7]   Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release [J].
Benedek, Irma H. ;
Jobes, Janet ;
Xiang, Qinfang ;
Fiske, William D. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 :455-463
[8]   A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States [J].
Blieden, Marissa ;
Paramore, L. Clark ;
Shah, Dhvani ;
Ben-Joseph, Rami .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) :341-348
[9]   Prescription Opioids. II. Metabolism and Excretion Patterns of Hydrocodone in Urine Following Controlled Single-Dose Administration [J].
Cone, Edward J. ;
Heltsley, Rebecca ;
Black, David L. ;
Mitchell, John M. ;
LoDico, Charles P. ;
Flegel, Ronald R. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2013, 37 (08) :486-494
[10]  
Darwish M, 2012, J PAIN, V13, pS77